John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Foresite Capital Management V LLC Has $11.05 Million Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Chairman at Iovance Biotherapeutics, Inc., Discover Iain Dukes's known position history, network and 100 relationships. Find out about his known public assets.
As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus.
/PRNewswire/ The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during the.